Djemli-Shipkolye A, Gallice P, Coste T, Jannot M F, Tsimaratos M, Raccah D, Vague P
Department of Diabetology, University Hospital Timone, Marseille, France.
Metabolism. 2000 Jul;49(7):868-72. doi: 10.1053/meta.2000.6753.
The decrease in Na/K adenosine triphosphatase (ATPase) activity observed in several tissues of type 1 diabetic patients is thought to play a role in the development of long-term complications. Infusion of insulin may restore this enzyme activity in red blood cells (RBCs), and recent arguments have been developed for a similar role of C-peptide. The aims of this study were to determine whether insulin acts directly on the RBC enzyme and to evaluate the effect of C-peptide on Na/K ATPase activity. Thirty-nine C-peptide-negative type 1 diabetic patients were studied (blood glucose, 11.2 +/- 1.49 mmol/L; hemoglobin A1c [HbA1c], 8.9% +/- 0.1%, mean +/- SEM). Blood samples were obtained in the morning, before breakfast and insulin injection. Intact and living RBCs were resuspended in their own plasma and incubated with or without insulin (50 microU/mL) or C-peptide (6 nmol/L). Ex vivo by microcalorimetry, the heat produced after 1 hour by the enzyme-induced hydrolysis of adenosine triphosphate (ATP), was measured in a thermostated microcalorimeter at 37 degrees C. The results showed that Na/K ATPase activity was significantly increased by insulin (12.4 +/- 0.5 v 15.4 +/- 0.9 mW/L RBCs, P < .05, n = 23) but not by C-peptide (11.9 +/- 0.7 v 12.9 +/- 0.9 mW/L RBCs, NS, P = .26, n = 12). In another experiment, RBC suspensions were incubated at 37 degrees C in a water bath with or without insulin (50 microU/mL) or C-peptide (6 nmol/L) for 10 minutes. RBC membranes were isolated and Na/K ATPase activity was assessed by measuring inorganic phosphate release at saturating concentrations of all substrates. The results showed that insulin and C-peptide significantly increased RBC Na/K ATPase activity (342 +/- 25, P < .005 and 363 +/- 30, P < .005, respectively v255 +/- 22 nmol Pi x mg protein(-1) x h(-1), n = 14). We conclude that insulin and C-peptide act directly on RBC Na/K ATPase, thus restoring this activity in type 1 diabetic patients. The stimulatory effect of C-peptide observed in vitro on RBC Na/K ATPase activity confirms that C-peptide plays a physiological role.
在1型糖尿病患者的多个组织中观察到的钠/钾三磷酸腺苷酶(ATP酶)活性降低被认为在长期并发症的发生发展中起作用。输注胰岛素可能会恢复红细胞(RBC)中的这种酶活性,并且最近有人提出C肽也有类似作用。本研究的目的是确定胰岛素是否直接作用于RBC酶,并评估C肽对钠/钾ATP酶活性的影响。对39例C肽阴性的1型糖尿病患者进行了研究(血糖,11.2±1.49 mmol/L;糖化血红蛋白[HbA1c],8.9%±0.1%,均值±标准误)。在早餐前和胰岛素注射前的早晨采集血样。完整的活红细胞重悬于自身血浆中,并与有或无胰岛素(50微单位/毫升)或C肽(6纳摩尔/升)一起孵育。通过微量量热法进行体外实验,在37℃的恒温微量量热计中测量1小时后由酶诱导的三磷酸腺苷(ATP)水解产生的热量。结果显示,胰岛素可显著增加钠/钾ATP酶活性(12.4±0.5对15.4±0.9毫瓦/升RBC,P<0.05,n = 23),但C肽无此作用(11.9±0.7对12.9±0.9毫瓦/升RBC,无显著性差异,P = 0.26,n = 12)。在另一项实验中,将RBC悬液在37℃的水浴中与有或无胰岛素(50微单位/毫升)或C肽(6纳摩尔/升)一起孵育10分钟。分离RBC膜,并通过测量所有底物饱和浓度下无机磷酸盐的释放来评估钠/钾ATP酶活性。结果显示,胰岛素和C肽均显著增加RBC钠/钾ATP酶活性(分别为342±25,P<0.005和363±30,P<0.005,对比255±22纳摩尔磷酸根×毫克蛋白⁻¹×小时⁻¹,n = 14)。我们得出结论,胰岛素和C肽直接作用于RBC钠/钾ATP酶,从而恢复1型糖尿病患者的这种活性。体外观察到的C肽对RBC钠/钾ATP酶活性的刺激作用证实了C肽发挥着生理作用。